129 related articles for article (PubMed ID: 30907195)
1. Extra-Adrenal Adult Neuroblastoma With Aberrant Germ Cell Marker Expression: Maturation After Chemotherapy as an Important Clue to a Challenging Diagnosis.
Martinez-Ciarpaglini C; Machado I; Yoshida A; Nieto G; Berbegall AP; Blanquer-Maceíras MT; Noguera R; Ferrández A; Navarro S
Int J Surg Pathol; 2019 Aug; 27(5):568-573. PubMed ID: 30907195
[TBL] [Abstract][Full Text] [Related]
2. Anaplastic large cell neuroblastoma.
Abramowsky CR; Katzenstein HM; Alvarado CS; Shehata BM
Pediatr Dev Pathol; 2009; 12(1):1-5. PubMed ID: 18397155
[TBL] [Abstract][Full Text] [Related]
3. Localized dumbbell neuroblastoma: a study of 25 cases treated between 1982 and 1987 using the same protocol.
Plantaz D; Hartmann O; Kalifa C; Sainte-Rose C; Lemoine G; Lemerle J
Med Pediatr Oncol; 1993; 21(4):249-53. PubMed ID: 8469218
[TBL] [Abstract][Full Text] [Related]
4. [Clinical characteristics and treatment of desmoplastic small round cell tumor].
Xing PY; Shi YK; Feng FY; Qin Y; Liu P
Zhonghua Zhong Liu Za Zhi; 2010 Feb; 32(2):139-42. PubMed ID: 20403246
[TBL] [Abstract][Full Text] [Related]
5. PHOX2B reliably distinguishes neuroblastoma among small round blue cell tumours.
Hung YP; Lee JP; Bellizzi AM; Hornick JL
Histopathology; 2017 Nov; 71(5):786-794. PubMed ID: 28640941
[TBL] [Abstract][Full Text] [Related]
6. Malignant pleural mesothelioma in a child: long-term survival with ICE-WAC chemotherapy regimen.
Mutafoğlu-Uysal K; Kargi A; Sarialioğlu F; Olgun N; Kovanlikaya A
Turk J Pediatr; 2002; 44(3):244-7. PubMed ID: 12405438
[TBL] [Abstract][Full Text] [Related]
7. Image-defined risk factor assessment of neurogenic tumors after neoadjuvant chemotherapy is useful for predicting intra-operative risk factors and the completeness of resection.
Irtan S; Brisse HJ; Minard-Colin V; Schleiermacher G; Galmiche-Rolland L; Le Cossec C; Elie C; Canale S; Michon J; Valteau-Couanet D; Sarnacki S
Pediatr Blood Cancer; 2015 Sep; 62(9):1543-9. PubMed ID: 25820608
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of efficacy of treatment for 30 children with neuroblastoma].
Sun XF; Liu DG; Su YS; Lin TY; Chen XQ; He YJ
Ai Zheng; 2003 Dec; 22(12):1343-5. PubMed ID: 14693065
[TBL] [Abstract][Full Text] [Related]
9. Treatment of advanced neuroblastoma: feasibility and therapeutic potential of a novel approach combining 131-I-MIBG and multiple drug chemotherapy.
Mastrangelo S; Tornesello A; Diociaiuti L; Pession A; Prete A; Rufini V; Troncone L; Mastrangelo R
Br J Cancer; 2001 Feb; 84(4):460-4. PubMed ID: 11207038
[TBL] [Abstract][Full Text] [Related]
10. Case report: value of gene expression profiling in the diagnosis of atypical neuroblastoma.
Harttrampf AC; Chen Q; Jüttner E; Geiger J; Vansant G; Khan J; Kontny U
BMC Res Notes; 2017 Aug; 10(1):413. PubMed ID: 28818093
[TBL] [Abstract][Full Text] [Related]
11. [Abdominal neuroblastoma in childhood: diagnostic and therapeutic aspects. Apropos of 26 cases].
Hentati M; Sayed S; Nouri A; Saïed H
Tunis Med; 1987; 65(6-7):423-6. PubMed ID: 3505379
[No Abstract] [Full Text] [Related]
12. [Neoadjuvant treatment of Ewing's sarcoma: results obtained in 122 patients treated with a 6-drug chemotherapeutic protocol (vincristine, adriamycin, cyclophosphamide, dactinomycin, ifosfamide and etoposide)].
Bacci G; Ferrari S; Rosito P; Barbieri E; Mercuri M; Brach del Prever A; Iantorno D; Forni C; Campanacci M
Minerva Pediatr; 1995 Nov; 47(11):457-69. PubMed ID: 8684341
[TBL] [Abstract][Full Text] [Related]
13. PHOX2B is a reliable immunomarker in distinguishing peripheral neuroblastic tumours from CNS embryonal tumours.
Alexandrescu S; Paulson V; Dubuc A; Ligon A; Lidov HG
Histopathology; 2018 Sep; 73(3):483-491. PubMed ID: 29758594
[TBL] [Abstract][Full Text] [Related]
14. Response and survival of patients with metastatic neuroblastoma after combination chemotherapy with adriamycin (NSC-123127), cyclophosphamide (NSC-26271), and vincristine (NSC-67574).
Gasparini M; Bellani FF; Musumeci R; Bonadonna G
Cancer Chemother Rep; 1974; 58(3):365-70. PubMed ID: 4601666
[No Abstract] [Full Text] [Related]
15. Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma.
Horibe K; Fukuda M; Miyajima Y; Matsumoto K; Kondo M; Inaba J; Miyashita Y
Med Pediatr Oncol; 2001 Jan; 36(1):203-4. PubMed ID: 11464885
[TBL] [Abstract][Full Text] [Related]
16. Stage 4S neuroblastoma, a disseminated tumor with excellent outcome.
Elimam NA; Atra AA; Fayea NY; Al-Asaad TG; Khattab TM; Al-Sulami GA; Felimban SK
Saudi Med J; 2006 Nov; 27(11):1734-6. PubMed ID: 17106552
[TBL] [Abstract][Full Text] [Related]
17. HuC/D expression in small round cell tumors and neuroendocrine tumors: a useful tool for distinguishing neuroblastoma from childhood small round cell tumors.
Takemoto J; Kuda M; Kohashi K; Yamada Y; Koga Y; Kinoshita I; Souzaki R; Taguchi T; Oda Y
Hum Pathol; 2019 Mar; 85():162-167. PubMed ID: 30468801
[TBL] [Abstract][Full Text] [Related]
18. [Observation of regression of generalized neuroblastoma in a child].
Litovka VK; Zhurilo IP; Veselyĭ SV
Klin Khir; 2002 Oct; (10):57-8. PubMed ID: 12448102
[No Abstract] [Full Text] [Related]
19. All children with malignant rhabdoid tumors should be treated initially with intensive chemotherapy.
Hernández-Marqués C; Lassaletta A; Cormenzana M; García-Esparza E; Madero-López L
Pediatr Hematol Oncol; 2015 Apr; 32(3):193-8. PubMed ID: 24852450
[TBL] [Abstract][Full Text] [Related]
20. Neuroblastoma.
Duckett JW; Koop CE
Urol Clin North Am; 1977 Jun; 4(2):285-95. PubMed ID: 331618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
